Target intelligence / Profile preview

Type I Nitroreductase (NTR I)

Target
NTR I
Molecular classification
Enzyme, Oxidoreductase, Flavoenzyme
01

Overview

Type I nitroreductases are oxygen-insensitive flavoenzymes that catalyze the two-electron reduction of nitroaromatic compounds and quinones, utilizing NADH or NADPH as electron donors. They are found in bacteria and some eukaryotes, including protozoan parasites. They play a role in xenobiotic detoxification, prodrug activation (e.g., in antiparasitic therapy), and are exploited in gene-directed enzyme prodrug therapy (GDEPT) for cancer treatment. Unlike Type II nitroreductases, they do not generate reactive oxygen species.

Other names
Oxygen-insensitive nitroreductaseNTR type I
02

Mechanism of action

Reduction of nitroaromatic compounds and quinones, activating prodrugs or detoxifying xenobiotics.

03

Biological functions

DetoxificationProdrug activationRedox balanceUbiquinone reduction (in some organisms)
04

Disease associations

Infection (drug resistance/sensitivity in bacteria and protozoa)Cancer (GDEPT)
05

Safety considerations

Potential for off-target effects in GDEPTDevelopment of resistance in bacteria and protozoa
06

Interacting drugs

Nitrofurans

3 more in the full profile.

Beyond the preview

Go deeper on Type I Nitroreductase (NTR I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type I Nitroreductase (NTR I).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call